Infectious Diseases News and Research

RSS

Good Trials Prism: A new partnership to enhance clinical research in low resource settings

Four major clinical trial networks based in low resource settings are embarking on an exciting partnership with the Good Clinical Trials Collaborative to enhance clinical research in low resource settings.

10 Aug 2023

Exploring molecular mechanisms and genetic dysregulation in aging and age-associated diseases

Researchers review existing data on the molecular basis of senescence and neurodegeneration in age-related brain diseases.

10 Aug 2023

Hepatitis C treatment initiation found to be low among Medicaid recipients

While there are highly effective treatments for the hepatitis C virus (HCV), only 1 in 5 Medicaid enrollees diagnosed with HCV started treatment, according to a retrospective study led by researchers at Weill Cornell Medicine and Cornell University's Ithaca campus.

8 Aug 2023

SLU research finds link between anxiety disorders, benzodiazepine exposure and dementia in seniors

Research from Saint Louis University School of Medicine finds that among patients 65 and older, a diagnosis of anxiety was significantly associated with an increased risk of dementia diagnosis, and benzodiazepine exposure was associated with a 28% increased risk of dementia.

7 Aug 2023

Phage therapy shows promise in treating tough Pseudomonas aeruginosa infections

A new international study conducted by the Israeli Phage Therapy Center (IPTC) led by Prof. Ran Nir-Paz at Hadassah Hebrew University Medical Center and Prof. Ronen Hazan of the Faculty of Dental Medicine at The Hebrew University of Jerusalem, using phage PASA16 on compassionate basis to treat tough Pseudomonas aeruginosa infections, has shown promising results with an 86.6% success rate.

7 Aug 2023

UKHSA unveils world-leading Vaccine Development and Evaluation Centre

The UK Health Security Agency (UKHSA) has today unveiled its world-leading Vaccine Development and Evaluation Centre (VDEC), which is building on its pandemic legacy and helping develop life-saving new vaccines for the UK and worldwide.

7 Aug 2023

Insilico Medicine's new AI tool shows promise in predicting clinical trial outcomes

Insilico Medicine ("Insilico"), a clinical-stage end-to-end generative artificial intelligence (AI) drug discovery company, has demonstrated that it can predict the outcome of Phase II to Phase III clinical trial success using its proprietary transformer-based AI clinical trial prediction tool called inClinico with a high degree of accuracy.

3 Aug 2023

NIH awards $18 million to develop novel chikungunya vaccine

The Access to Advanced Health Institute (AAHI) announced today that it has received an $18 million award from the National Institutes of Health (NIH) to develop a temperature stable, single-dose vaccine candidate for the chikungunya virus.

3 Aug 2023

Child-friendly HIV drug could improve treatment outcomes

Researchers at the University of Colorado Anschutz Medical Campus have helped confirm the dosing, safety and effectiveness of a drug formulation designed for treating children with human immunodeficiency virus (HIV).

2 Aug 2023

Insilico Medicine uses AI to discover novel SIK2 inhibitors

Insilico Medicine ("Insilico"), a clinical-stage end-to-end generative artificial intelligence (AI) drug discovery company, has achieved a significant breakthrough in the application of multiple generative AI models and AlphaFold structures for drug discovery.

2 Aug 2023

Novel molecules inspired by the immune system inactivate several viruses

Antiviral therapies are notoriously difficult to develop, as viruses can quickly mutate to become resistant to drugs. But what if a new generation of antivirals ignores the fast-mutating proteins on the surface of viruses and instead disrupts their protective layers?

2 Aug 2023

Peptoid antiviral therapy inactivates three viruses in lab tests

Just as bacteria can develop antibiotic resistance, viruses can also evade drug treatments. Developing therapies against these microbes is difficult because viruses often mutate or hide themselves within cells.

2 Aug 2023

Study assesses the value of predictive biomarkers for early-stage COVID-19 infection

Researchers illustrated that certain biomarkers may be better predictors of COVID-19 than others.

2 Aug 2023

Three doses of mRNA vaccine provide good protection for vulnerable people

Even vulnerable people, who are at risk of severe Covid-19, achieved good antibody levels after three doses of mRNA vaccine.

1 Aug 2023

Research reveals surprising genetic overlap between neurological and psychiatric disorders

Researchers compared the shared genetic risk and biological foundations of neurological and mental illnesses.

1 Aug 2023

Metagenomic next-generation sequencing as an emerging modality for the diagnosis of infectious diseases

Study examined the role of plasma metagenomic next-generation sequencing.

1 Aug 2023

New device can detect COVID-19 in less than a minute

Benjamin Sumlin, PhD, a senior scientist at Washington University in St. Louis, blows into a device designed by researchers at the university. The device — a breath test that uses a biosensor — could become a tool for use in doctors' offices to quickly diagnose people infected with the virus that causes COVID-19.

1 Aug 2023

Anemia: A global health problem with wide disparities

Anemia affected nearly 2 billion people in 2021, impacting women to a greater degree than men. In a new study covering three decades of global anemia data (1990–2021), a complex picture emerges of how several key factors play into the divergence in success stories among men, women, and children.

31 Jul 2023

Novel noninvasive test for malaria does not require a blood sample

A novel testing platform under development by researchers at the Yale School of Public Health (YSPH) and CytoAstra, LLC could provide a new noninvasive test for malaria that doesn't require a blood sample.

28 Jul 2023

Study illuminates new connections between diet and immunity

A metabolic by-product that is more prevalent during fasting may supercharge immune cells as they fight infection and disease, reports an early stage study by Van Andel Institute scientists and collaborators.

28 Jul 2023

Infectious Diseases News and Research

Good Trials Prism: A new partnership to enhance clinical research in low resource settings

Exploring molecular mechanisms and genetic dysregulation in aging and age-associated diseases

Hepatitis C treatment initiation found to be low among Medicaid recipients

SLU research finds link between anxiety disorders, benzodiazepine exposure and dementia in seniors

Phage therapy shows promise in treating tough Pseudomonas aeruginosa infections

UKHSA unveils world-leading Vaccine Development and Evaluation Centre

Insilico Medicine's new AI tool shows promise in predicting clinical trial outcomes

NIH awards $18 million to develop novel chikungunya vaccine

Child-friendly HIV drug could improve treatment outcomes

Insilico Medicine uses AI to discover novel SIK2 inhibitors

Novel molecules inspired by the immune system inactivate several viruses

Peptoid antiviral therapy inactivates three viruses in lab tests

Study assesses the value of predictive biomarkers for early-stage COVID-19 infection

Three doses of mRNA vaccine provide good protection for vulnerable people

Research reveals surprising genetic overlap between neurological and psychiatric disorders

Metagenomic next-generation sequencing as an emerging modality for the diagnosis of infectious diseases

New device can detect COVID-19 in less than a minute

Anemia: A global health problem with wide disparities

Novel noninvasive test for malaria does not require a blood sample

Study illuminates new connections between diet and immunity

NGS for Infectious Disease Surveillance eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News